Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.47, Iss.1, 1998-01, pp. : 47-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Premenopausal node-negative breast cancer: May adjuvant chemotherapy be indicated by the analysis of nuclear DNA dynamics?

By Wyss-desserich M-T.

Breast Cancer Research and Treatment, Vol. 42, Iss. 3, 1997-02 ,pp. : 253-263

Springer Publishing Company

Access to resources Recommend Favorite

Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer?

By Galimberti Viviana

Breast Cancer Research and Treatment, Vol. 131, Iss. 3, 2012-02 ,pp. : 819-825

Springer Publishing Company

Access to resources Recommend Favorite

Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer?

By Hurria Arti Lachs Mark

Breast Cancer Research and Treatment, Vol. 103, Iss. 3, 2007-07 ,pp. : 259-268

Springer Publishing Company

Access to resources Recommend Favorite

Should bisphosphonates be utilized in the adjuvant setting for breast cancer?

By Lipton Allan

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 627-636

Springer Publishing Company

Access to resources Recommend Favorite

Hypothesis: is antibiotic use associated with breast cancer?

By Velicer Christine M.

Cancer Causes and Control, Vol. 14, Iss. 8, 2003-01 ,pp. : 739-747

Springer Publishing Company

Access to resources Recommend Favorite